Abstract | BACKGROUND:
Micafungin is a new and very useful pharmacological tool for the treatment of invasive mycoses with a wide antifungal spectrum for the most common pathogenic fungi. Micafungin is especially active against the genera Candida and Aspergillus. Its antifungal mechanism is based on the inhibition of the beta-1,3- D-glucan synthesis, an essential molecule for the cell wall architecture, with different con sequences for Candida and Aspergillus, being micafungin fungicide for the former and fungistatic for the latter. AIM: To describe the in vitro antifungal spectrum of micafungin based in the scientific and medical lite rature of recent years. METHODS: We have done a bibliographic retrieval using the scientific terms, " micafungin", "activity", "Candida", "Aspergillus", "fungi", "mycos*", "susceptibility", in PubMed/Medline from the National Library of Medicine de EE.UU. from 2005 to 2009. RESULTS: We can underline that most than 99% of Candida isolates are susceptible to < or = 2microg/ml of micafungin. MIC are very low (< or = 0.125microg/ml) for most clinical isolates of the species Candida albicans, Candida glabrata, Candida tropicalis and Candida krusei while Candida parapsilosis and Candida guilliermondii isolates are susceptible to anidulafungin concentrations < or = 2microg/ml. The activity of micafungin is excellent against those medical important species of Aspergillus. However, its activity is very low against Cryptococcus and the Zygomycetes. CONCLUSIONS:
|
Authors | Guillermo Quindós, Elena Eraso, Alfonso Javier Carrillo-Muñoz, Emilia Cantón, Javier Pemán |
Journal | Revista iberoamericana de micologia
(Rev Iberoam Micol)
Vol. 26
Issue 1
Pg. 35-41
(Mar 31 2009)
ISSN: 1130-1406 [Print] Spain |
Vernacular Title | Actividad antifúngica in vitro de la micafungina. |
PMID | 19463275
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, Review)
|
Chemical References |
- Antifungal Agents
- Echinocandins
- Lipopeptides
- Micafungin
|
Topics |
- Antifungal Agents
(pharmacology, therapeutic use)
- Aspergillus
(drug effects)
- Candida
(drug effects)
- Cryptococcus
(drug effects)
- Drug Evaluation, Preclinical
- Drug Resistance, Fungal
- Drug Synergism
- Echinocandins
(pharmacology, therapeutic use)
- Fungi
(drug effects)
- Humans
- In Vitro Techniques
- Lipopeptides
(pharmacology, therapeutic use)
- Micafungin
- Microbial Sensitivity Tests
- Mycoses
(drug therapy)
- Species Specificity
|